Clinical trials
Phase 1 Diffuse Intrinsic Pontine Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 13 |
| Active, not recruiting | 8 |
| Terminated | 7 |
| Not yet recruiting | 4 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| St. Jude Children's Research Hospital | 4 |
| Nationwide Children's Hospital | 3 |
| University of Florida | 3 |
| Capital Medical University | 2 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| Columbia University | 2 |
| Emory University | 2 |
| M.D. Anderson Cancer Center | 2 |
| Pediatric Brain Tumor Consortium | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diffuse Intrinsic Pontine Glioma | 56 |
| Glioma | 32 |
| Brain Neoplasms | 17 |
| Medulloblastoma | 13 |
| Glioblastoma | 11 |
| Astrocytoma | 9 |
| Rhabdoid Tumor | 8 |
| Central Nervous System Neoplasms | 5 |
| Ependymoma | 5 |
| Neuroblastoma | 4 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.